Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
Trump Blocks HieFo’s Emcore Chip Assets Deal Over National Security Concerns 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Grok AI Faces Global Scrutiny Over Safeguard Failures and Illegal Content on X 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
BURLINGTON, Mass., Oct. 23, 2017 -- Nuance Communications, Inc. (NASDAQ:NUAN) today announced it has filed a patent infringement lawsuit in the U.S. Federal District Court of Delaware against M*Modal. The lawsuit alleges that M*Modal products violate six Nuance patents related to speech recognition, computer-assisted physician documentation and transcription technology applied in the healthcare IT market. This lawsuit is based on U.S. Patent nos. 9,564,126; 8,117,034; 7,379,946; 6,999,933; 6,766,295; and 6,308,158.
“Nuance has invested significant human and financial resources in developing innovations and building an intellectual property portfolio that are important components of our strategy and integral to the success of our business,” said David Greenbaum, Vice President of Litigation & Intellectual Property, Nuance. “Our IP and technology assets favorably differentiate our voice- and AI-powered offerings in the healthcare industry. We take great pride in, and place significant value on, our patents and will protect our rights.”
Nuance Healthcare provides intelligent systems that support a more natural and insightful approach to clinical documentation, freeing clinicians to spend more time caring for patients. Nuance healthcare’s award-winning solutions capture more than 300 million patient stories each year, delivering real-time clinical guidance at the point of decision making across the continuum of care. With deep partner integrations across the healthcare ecosystem and decades of clinical expertise, Nuance Healthcare provides a more complete and accurate view of patient care to improve the clinical and financial outcomes for more than 500,000 clinicians in 10,000 global healthcare organizations.
About Nuance Communications, Inc.
Nuance Communications, Inc. (NASDAQ:NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance’s proven applications. For more information, please visit www.nuance.com.
Trademark reference: Nuance and the Nuance logo are registered trademarks or trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other trademarks referenced herein are the property of their respective owners.
Media Contact:
Rick Mack
Nuance Communications, Inc.
Tel: (781) 565-5000
Email: [email protected]
